ArticleInternational journal of molecular sciences2026
In Silico Comparative Analysis of the Plant Growth Regulators Forchlorfenuron (CPPU) and Strigol (STG) Interacting with the Gibberellin Biosynthetic Enzyme GA3Ox2 and the Auxin Signaling Protein Receptor IAA7.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant growth regulation is orchestrated by complex hormonal networks involving gibberellin and auxin signaling pathways. In this study, a comprehensive in silico approach was employed to comparatively evaluate the plant growth regulators (PGRs) forchlorfenuron (CPPU) and strigol (STG) against two key proteins from Arabidopsis thaliana: Gibberellin 3-beta-dioxygenase 2 (GA3Ox2), a rate-limiting enzyme in the biosynthesis of bioactive gibberellins, and the auxin signaling repressor IAA7. These targets were specifically selected because they represent critical regulatory nodes in two major hormonal pathways controlling plant growth: GA3Ox2 governs the final steps of gibberellin activation, while IAA7 modulates auxin-responsive gene expression through its interaction with Auxin Response Factors. Therefore, their combined analysis enables the evaluation of potential regulatory effects of PGRs on both gibberellin biosynthesis and auxin-mediated transcriptional control. Molecular docking analyses revealed that both ligands exhibited higher binding affinity toward GA3Ox2 than IAA7, with STG showing slightly more favorable binding energies (-7.91 kcal/mol for GA3Ox2 and -5.43 kcal/mol for IAA7) compared to CPPU (-7.18 and -4.79 kcal/mol, respectively). These results suggest a structural preference of both PGRs toward the gibberellin biosynthetic pathway. To further assess complex stability under near-physiological conditions, 100 ns molecular dynamics (MD) simulations were conducted using the CHARMM36m force field. Despite its slightly lower docking scores, CPPU demonstrated greater conformational stability, lower RMSD fluctuations, and more persistent hydrogen bonding patterns, particularly in complexes with IAA7. In contrast, STG induced more pronounced conformational rearrangements, although it promoted slightly more compact protein conformations in certain systems. Fourier-transform infrared (FTIR) spectroscopy supported the computational findings by confirming the presence of key functional groups responsible for hydrogen bonding and hydrophobic interactions. Collectively, the results indicate that although STG exhibits higher initial binding affinity, CPPU forms more dynamically stable complexes with both proteins. These findings suggest that CPPU may represent a more robust candidate for sustained modulation of auxin and gibberellin signaling pathways in plant growth regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.